DAYVIGO (Eisai Australia Pty Ltd)
Product name
DAYVIGO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
224 (255 working days)
Active ingredients
lemborexant
Registration type
NCE/NBE
Indication
DAYVIGO (film coated tablet) is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance in accordance with latest DSM criteria.